Stock Earnings

Question 1

Quels sont les états financiers clés de Axsome Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Axsome Therapeutics Inc a un total d'actifs de $568, un bénéfice net loss de $-287

Question 2

Quels sont les ratios financiers clés pour AXSM ?

Accepted Answer

Le ratio de liquidité de Axsome Therapeutics Inc est 1.11, la marge nette est -74.54, les ventes par action sont de $8.03.

Question 3

Comment les revenus de Axsome Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Axsome Therapeutics Inc largest revenue segment is Novel Therapies for the Management of Central Nervous System Disorders, at a revenue of 385,693,000 in the most earnings release.For geography, United States is the primary market for Axsome Therapeutics Inc, at a revenue of 378,159,000.

Question 4

Axsome Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Axsome Therapeutics Inc a un bénéfice net loss de $-287

Question 5

Axsome Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Axsome Therapeutics Inc a un passif de 511

Question 6

Combien d'actions en circulation Axsome Therapeutics Inc a-t-elle ?

Accepted Answer

Axsome Therapeutics Inc a un total d'actions en circulation de 49

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	495	385	270	50	0	0
Revenue Growth (YoY)	70%	43%	440%	--	--	--
Cost of Revenue	42	33	26	5	--	--
Gross Profit	452	352	244	44	--	--
Selling, General & Admin	462	411	323	158	66	28
Research & Development	194	187	97	57	58	70
Operating Expenses	684	632	476	224	124	99
Other Non Operating Income (Expenses)	--	--	--	0	0	0
Pretax Income	-247	-287	-238	-187	-130	-102
Income Tax Expense	0	0	0	--	--	--
Net Income	-246	-287	-239	-187	-130	-102
Net Income Growth	-20%	20%	28%	44%	27%	50%
Shares Outstanding (Diluted)	49.44	47.91	45.42	40.66	37.62	37.21
Shares Change (YoY)	4%	5%	12%	8%	1%	9%
EPS (Diluted)	-4.99	-5.99	-5.26	-4.6	-3.47	-2.77
EPS Growth	-23%	14%	14%	33%	25%	38%
Free Cash Flow	-121	-128	-145	-117	-108	-78
Free Cash Flow Per Share	-2.44	-2.67	-3.19	-2.87	-2.87	-2.09
Gross Margin	91.31%	91.42%	90.37%	88%	--	--
Operating Margin	-46.66%	-72.72%	-85.55%	-358%	0%	0%
Profit Margin	-49.69%	-74.54%	-88.51%	-374%	0%	0%
Free Cash Flow Margin	-24.44%	-33.24%	-53.7%	-234%	0%	0%
EBITDA	-223	-273	-225	-175	-124	-99
EBITDA Margin	-45.05%	-70.9%	-83.33%	-350%	0%	0%
D&A For EBITDA	8	7	6	4	0	0
EBIT	-231	-280	-231	-179	-124	-99
EBIT Margin	-46.66%	-72.72%	-85.55%	-358%	0%	0%
Effective Tax Rate	0%	0%	0%	--	--	--

Axsome Therapeutics Inc (AXSM) Price

AXSM Stock Price Chart

AXSM Income

Follow-Up Questions